PMA P110019S049

Device
XIENCE PRIME EECSS (XIENCE PRIME AND XIENCE PRIME LONG LENGTHS [LL])
Applicant
Abbott Vascular
PMA number
P110019
Supplement
S049
Product code
NIQ
Decision date
2013-06-27
Classification
Coronary Drug-eluting Stent
Generic name
Coronary drug-eluting stent
Approval order statement
CHANGE TO THE APHA COLOR TEST METHOD FOR A SOLVENT USED IN THE MANUFACTURING OF AV¿S DEVICE-DRUG COMBINATION PRODUCTS.

Current openFDA PMA Record#

Device
XIENCE PRIME EECSS (XIENCE PRIME AND XIENCE PRIME LONG LENGTHS [LL])
Applicant
Abbott Vascular
PMA number
P110019
Supplement
S049
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2013-06-27
Decision code
OK30
Date received
2013-05-31
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
CHANGE TO THE APHA COLOR TEST METHOD FOR A SOLVENT USED IN THE MANUFACTURING OF AV¿S DEVICE-DRUG COMBINATION PRODUCTS.